查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971326

生物基聚丙烯醫療設備市場－全球產業規模、佔有率、趨勢、機會和預測：按應用、地區和競爭格局分類，2021-2031年

Bio-based Polypropylene in Medical Devices Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Application (Heart Valve Structures, Surgery Sutures, Surgical Mesh, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療設備用生物基聚丙烯市場預計將從 2025 年的 119.6 億美元成長到 2031 年的 204.1 億美元，複合年成長率為 9.32%。

用於醫療領域的生物基聚丙烯是一種熱塑性聚合物，由玉米、甘蔗和廢油等可再生資源製成，旨在減少碳排放，同時提供與化石基聚丙烯相當的機械性能和耐化學性。推動該市場發展的關鍵因素包括醫療產業迫切需要減少對環境的影響，以及對永續採購日益嚴格的監管。這些因素不僅顯示了一種技術趨勢，也預示著供應鏈脫碳結構轉型的基礎。歐洲生質塑膠協會的報告顯示，到2024年，全球生質塑膠產能將達到247萬噸，凸顯了擴大工業規模以滿足永續採購需求的必要性。

市場概覽
預測期 2027-2031
市場規模：2025年 119.6億美元
市場規模：2031年 204.1億美元
複合年成長率：2026-2031年 9.32%
成長最快的細分市場 手術縫合線
最大的市場 北美洲

另一方面，市場擴張的一大障礙是醫用級材料必須經過嚴格的檢驗和再認證程序。以生物基替代品取代傳統聚丙烯需要進行全面的測試，以確保符合監管要求和生物相容性，這會導致成本大幅增加，並延緩現有製造商進入市場。由於病患安全至關重要，這些生物基替代品在被採用之前必須經過嚴格審查，儘管它們具有明顯的環保優勢，但這仍然阻礙了它們取代傳統塑膠。

市場促進因素

嚴格的法規結構的實施，旨在促進永續材料的使用，是重塑全球醫療設備用生物基聚丙烯市場的主要驅動力。隨著醫療保健系統向脫碳方向發展，採購要求積極要求減少範圍3排放，迫使製造商從化石資源轉向生物基聚合物，以確保合規並維持市場進入。例如，英國國家醫療服務體系（NHS England）已擴大了供應商公佈「碳減排計劃」的要求，自2024年4月起，所有新採購項目均需提交該計劃，這直接要求醫療設備供應商提供檢驗的排放證明。根據Think Global Health的數據顯示，截至2024年2月，醫療保健產業約佔全球溫室氣體排放總量的4.4%，凸顯了材料轉型的迫切性，而這項轉型至關重要。

此外，專注於生物材料探索和商業化的策略性產業合作正在透過克服供應鏈和檢驗障礙來加速市場擴張。化學品製造商正與醫療設備製造商直接合作，開發符合嚴格生物相容性要求的醫用級生物基聚丙烯，同時提高產能。這些合作確保了生物基材料在技術上可靠，並商業性以足夠的數量實現大規模生產。例如，利安德巴塞爾在其2024年永續發展報告中重申了其目標，即到2030年每年生產和銷售至少200萬噸由回收和可再生原料衍生的聚合物。這種在策略夥伴關係支援下實現的擴張對於在包裝和一次性注射器等大批量應用領域取代傳統聚丙烯至關重要。

市場挑戰

醫用級材料所需的全面檢驗和再認證流程是生物基聚丙烯市場成長的主要障礙。醫療設備製造商必須遵守嚴格的安全標準，並且在用生物基替代品取代傳統聚丙烯時，必須啟動強制性的、廣泛的測試通訊協定。這些流程包括全面的生物相容性評估和長期穩定性測試，以確保新材料不會對病人安全構成威脅。由於再認證需要大量資金，且核准進度難以預測，製造商為了避免營運中斷，不得不優先選擇成熟的化石燃料供應鏈，而非永續的替代方案。

監管瓶頸正顯著減緩生物基醫療設備的商業化進程，造成原料供應與實際市場滲透率之間的差距。有效克服這些監管障礙所需的漫長流程，實際上延緩了旨在實現產品線脫碳的企業的投資回報。根據歐洲醫療技術協會（MedTech Europe）的報告顯示，到2024年，根據《醫療設備法規》（MDR），改良型醫療技術的平均認證時間將超過18個月。這種延誤阻礙了製造商採用生物基聚丙烯，因為市場准入的延遲所帶來的競爭風險超過了永續採購帶來的即時效益。

市場趨勢

經ISCC PLUS認證的MasmaBalance生物聚丙烯的商業化正迅速發展成為一大趨勢，使醫療設備製造商能夠在不改變其檢驗的生產基礎設施的情況下，採用永續聚合物。透過採用MasmaBalance方法，供應商可以將生物基積分分配給現有的化石基生產流程，從而確保檢驗的可追溯性，同時避免建造分離設施所需的高額資本投入。此方法對醫療產業至關重要，因為它克服了為高純度等級產品建設專用生物工廠所帶來的物流和經濟障礙。 2024年10月，ISCC系統在循環經濟相關人員大會上報告稱，全球有效的ISCC PLUS認證總數已超過4800項，這表明這種支持永續性聲明的管理鏈模式正在被工業界迅速採用。

同時，市場正發生結構性轉變，第二代廢棄物（例如焦油和廢棄食用油殘渣）正逐漸取代第一代糧食作物，成為市場主導。這項轉變不僅解決了與糧食供應競爭相關的倫理問題，而且與作物衍生產品相比，顯著降低了生物丙烯在其整個生命週期中的碳足跡。醫療設備製造商 (OEM) 正在加強對這些廢棄物衍生原料的採用力度，以滿足嚴格的循環經濟目標，同時又不影響臨床應用所需的化學可再生。例如，Neste 在截至 2024 年 3 月的財政年度報告中宣布，廢棄物和殘渣原料平均佔其可再生原料總投入的 92%，這鞏固了非糧食原料在可再生碳氫化合物聚合物生產中的主流地位。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：生物基聚丙烯醫療設備用全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依應用領域（心臟瓣膜結構、外科縫合線、外科網片等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美醫療設備用生物基聚丙烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫療設備用生物基聚丙烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生物基聚丙烯醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲醫療設備用生物基聚丙烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲醫療設備用生物基聚丙烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球生物基聚丙烯醫療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Saudi Basic Industries Corp
  • LyondellBasell Industries NV
  • Mitsui Chemicals Inc.
  • Borealis AG
  • Braskem SA
  • TotalEnergies SE
  • Danimer Scientific Inc
  • FAF Kunststofftechnik GmbH & Co KG
  • GreenMantra Recycling Technologies Ltd
  • Avient Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20077

The Global Bio-based Polypropylene in Medical Devices Market is projected to expand from USD 11.96 Billion in 2025 to USD 20.41 Billion by 2031, reflecting a compound annual growth rate of 9.32%. Bio-based polypropylene used in medical applications is a thermoplastic polymer produced from renewable sources like corn, sugarcane, or waste oils, engineered to offer identical mechanical performance and chemical resistance to fossil-based polypropylene while diminishing carbon emissions. The central forces driving this market include the healthcare industry's urgent requirement to reduce its environmental impact and intensifying regulatory demands for sustainable procurement. These drivers indicate a foundational structural transition toward supply chain decarbonization rather than simple technological trends. As reported by European Bioplastics, global bioplastics production capacity hit 2.47 million tonnes in 2024, highlighting the growing industrial scale necessary to meet these sustainable sourcing needs.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.96 Billion
Market Size 2031USD 20.41 Billion
CAGR 2026-20319.32%
Fastest Growing SegmentSurgery Sutures
Largest MarketNorth America

Conversely, a major hurdle limiting widespread market growth is the stringent validation and requalification procedure mandated for medical-grade materials. Substituting traditional polypropylene with a bio-based counterpart requires comprehensive testing to guarantee regulatory compliance and biocompatibility, resulting in significant expenses and delaying market entry for established producers. Because patient safety is paramount, these bio-based alternatives must undergo extensive scrutiny before adoption, creating a barrier that slows the replacement of conventional plastics despite the clear environmental benefits.

Market Driver

The enforcement of strict regulatory frameworks advocating for sustainable materials serves as the main engine reshaping the Global Bio-based Polypropylene in Medical Devices Market. As healthcare systems aim to decarbonize, procurement mandates are aggressively requiring the reduction of Scope 3 emissions, compelling manufacturers to shift from fossil-based resources to bio-based polymers to ensure compliance and retain market access. For example, NHS England expanded its requirement for suppliers to publish a Carbon Reduction Plan to encompass all new procurements starting in April 2024, directly obliging device suppliers to prove verified emission reductions. This transition is vital given that, according to Think Global Health, the global healthcare sector accounted for approximately 4.4 percent of all greenhouse gas emissions in February 2024, highlighting the urgent need for such material changes.

Furthermore, strategic industry collaborations focused on bio-material research and commercialization are accelerating market expansion by surmounting supply chain and validation obstacles. Chemical manufacturers are partnering directly with medical device companies to create medical-grade bio-based polypropylene that satisfies strict biocompatibility requirements while increasing production capabilities. These alliances ensure that bio-based options are technically sound and commercially available in quantities adequate for mass production. Illustrating this industrial dedication, LyondellBasell reiterated its target in its 2024 Sustainability Report to manufacture and sell at least 2 million metric tons of recycled and renewable-based polymers annually by 2030. Such expansion, underpinned by strategic partnerships, is crucial for substituting conventional polypropylene in high-volume uses like packaging and disposable syringes.

Market Challenge

The comprehensive validation and requalification process necessary for medical-grade materials represents a primary barrier curbing the growth of the bio-based polypropylene market. Medical device producers must comply with rigorous safety standards, implying that replacing conventional polypropylene with a bio-based equivalent initiates mandatory, extensive testing protocols. These procedures entail thorough biocompatibility evaluations and long-term stability studies to confirm that the new material presents no threat to patient safety. The significant capital needed for this requalification, along with the unpredictability of approval timelines, compels manufacturers to favor established fossil-based supply chains over sustainable options to prevent operational interruptions.

This regulatory bottleneck markedly retards the commercialization pace of bio-based devices, generating a gap between raw material supply and actual market uptake. The prolonged period needed to navigate these regulatory obstacles effectively postpones the return on investment for firms seeking to decarbonize their product lines. As stated by MedTech Europe, the average duration to finalize the regulatory certification process for modified medical technologies under the Medical Device Regulation was reported to surpass 18 months in 2024. Such extended lead times deter manufacturers from adopting bio-based polypropylene, as the delay in market entry introduces competitive risks that supersede the immediate advantages of sustainable procurement.

Market Trends

The commercialization of ISCC PLUS Certified Mass Balance Bio-PP is swiftly developing as a major trend, enabling medical device manufacturers to incorporate sustainable polymers without modifying their validated production infrastructure. By employing a mass balance method, suppliers assign bio-based credits to existing fossil-based manufacturing streams, effectively avoiding the capital-intensive requirement for segregated facilities while guaranteeing verifiable traceability. This approach is essential for the medical industry as it overcomes the logistical and economic hurdles of building dedicated bio-plants for high-purity grades. In October 2024, the ISCC System reported during its circular economy stakeholder meeting that the global count of valid ISCC PLUS certificates exceeded 4,800, indicating the rapid industrial uptake of this chain-of-custody model to substantiate sustainable claims.

Concurrently, the market is experiencing a structural shift toward Second-Generation Waste-Derived Feedstocks, favoring residues such as tall oil and used cooking oil over first-generation food crops. This transition resolves ethical issues concerning food supply competition and substantially reduces the lifecycle carbon footprint of the resulting bio-propylene relative to crop-based options. Medical OEMs are increasingly requesting these waste-derived grades to satisfy stringent circular economy objectives without sacrificing the chemical purity needed for clinical uses. Highlighting this supply chain progression, Neste disclosed in its March 2024 Annual Report that the proportion of waste and residue feedstocks averaged 92 percent of its total renewable material inputs, solidifying the prevalence of non-food sources in renewable hydrocarbon production for polymers.

Key Market Players

  • Saudi Basic Industries Corp
  • LyondellBasell Industries NV
  • Mitsui Chemicals Inc.
  • Borealis AG
  • Braskem SA
  • TotalEnergies SE
  • Danimer Scientific Inc
  • FAF Kunststofftechnik GmbH & Co KG
  • GreenMantra Recycling Technologies Ltd
  • Avient Corporation

Report Scope

In this report, the Global Bio-based Polypropylene in Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-based Polypropylene in Medical Devices Market, By Application

  • Heart Valve Structures
  • Surgery Sutures
  • Surgical Mesh
  • Others

Bio-based Polypropylene in Medical Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-based Polypropylene in Medical Devices Market.

Available Customizations:

Global Bio-based Polypropylene in Medical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio-based Polypropylene in Medical Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Heart Valve Structures, Surgery Sutures, Surgical Mesh, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Bio-based Polypropylene in Medical Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bio-based Polypropylene in Medical Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
    • 6.3.2. Canada Bio-based Polypropylene in Medical Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
    • 6.3.3. Mexico Bio-based Polypropylene in Medical Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application

7. Europe Bio-based Polypropylene in Medical Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
    • 7.3.2. France Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
    • 7.3.3. United Kingdom Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
    • 7.3.4. Italy Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
    • 7.3.5. Spain Bio-based Polypropylene in Medical Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application

8. Asia Pacific Bio-based Polypropylene in Medical Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
    • 8.3.2. India Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
    • 8.3.3. Japan Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
    • 8.3.4. South Korea Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
    • 8.3.5. Australia Bio-based Polypropylene in Medical Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application

9. Middle East & Africa Bio-based Polypropylene in Medical Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bio-based Polypropylene in Medical Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
    • 9.3.2. UAE Bio-based Polypropylene in Medical Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
    • 9.3.3. South Africa Bio-based Polypropylene in Medical Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application

10. South America Bio-based Polypropylene in Medical Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio-based Polypropylene in Medical Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
    • 10.3.2. Colombia Bio-based Polypropylene in Medical Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
    • 10.3.3. Argentina Bio-based Polypropylene in Medical Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bio-based Polypropylene in Medical Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Saudi Basic Industries Corp
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. LyondellBasell Industries NV
  • 15.3. Mitsui Chemicals Inc.
  • 15.4. Borealis AG
  • 15.5. Braskem SA
  • 15.6. TotalEnergies SE
  • 15.7. Danimer Scientific Inc
  • 15.8. FAF Kunststofftechnik GmbH & Co KG
  • 15.9. GreenMantra Recycling Technologies Ltd
  • 15.10. Avient Corporation

16. Strategic Recommendations

17. About Us & Disclaimer